Bioorganic and Medicinal Chemistry Letters p. 189 - 194 (1998)
Update date:2022-08-02
Topics:
Ojima, Iwao
Bounaud, Pierre-Yves
Takeuchi, Craig
Pera, Paula
Bernacki, Ralph J.
New non-cytotoxic taxanes synthesized from 10-deacetylbaccatin III and special hydrophobic acylating agents show remarkable MDR reversal activity (≤99.8%) against drug-resistant human breast cancer cells when co-administered with paclitaxel or doxorubicin. This activity is ascribed to the highly efficient blocking of P-glycoprotein efflux by these new taxanes.
View Morewebsite:http://www.mascot-ie.com
Contact:86-519-85010339
Address:B-802,XingBei Building,391#,Tongjiang Middle Road New District,Changzhou,JS,China
Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Taizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
Hangzhou Think Chemical Co. Ltd
website:http://www.thinkchem.com/
Contact:86-571-89986307/81956191/81956084/81956192
Address:Room 501-502, Tower E, Yuanjian Building, Yuanyang International Center, Hangzhou-310011, China
website:http://www.sagechem.com
Contact:+86-571-86818502
Address:Room C1301, New Youth Plaza, 8 Jia Shan Road, Hangzhou, China
Doi:10.1016/j.tet.2021.132387
(2021)Doi:10.1039/c3ob42341g
(2014)Doi:10.1021/jo01267a010
(1968)Doi:10.1016/j.tet.2015.05.115
(2015)Doi:10.1021/jm00052a010
(1994)Doi:10.1039/d1ob00942g
(2021)